Matthew E. Korenberg - Nov 30, 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon, Attorney-in-Fact for Matthew E. Korenberg
Stock symbol
LGND
Transactions as of
Nov 30, 2022
Transactions value $
-$261,930
Form type
4
Date filed
12/1/2022, 08:42 PM
Previous filing
Nov 3, 2022
Next filing
Dec 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$262K -3.59K -4.18% $72.90 82.4K Nov 30, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.